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Objective:  The  association  between  arterial  stiffness,  as measured  by the  cardio-ankle  vascular  index
(CAVI),  and  coronary  atherosclerosis,  using  coronary  artery  computed  tomography  (CT),  was  investi-
gated  in  the asymptomatic  general  population,  with  special  interest  in  subjects  with  abnormal  glucose
metabolism.
Patients  and methods:  A total  of  158  normoglycemic  subjects  and  373  subjects  with  abnormal  glucose
metabolism  were evaluated.  CAVI  was assessed  in  relation  with  coronary  artery  calcium  score  (CACS)
and degree  of  stenosis  detected  by CT.
Results:  The  association  of  CAVI with  other  clinical  parameters  was  evaluated  in  patients  with  abnormal
glucose  metabolism.  CAVI  was  higher,  and  CACS  and the degree  of  coronary  artery  stenosis  were  both
greater  compared  to the  normal  group.  CAVI  showed  a signiﬁcant  correlation  with  CACS  and  the  degree
of stenosis  (r  =  0.167,  p = 0.001;  r =  0.182,  p  <  0.001,  respectively).  The  cut-off  level  of  CAVI  from  receiver
operating  characteristic  (ROC)  curve  was  ≥8.0  for  predicting  ≥50%  coronary  artery  stenosis  (area  under
the curve  0.713,  sensitivity  69%,  and speciﬁcity  61%).  CAVI  ≥8.0  was  independently  associated  with  sig-
niﬁcant  coronary  artery  stenosis,  even  after  adjusting  for  age,  sex,  and  presence  of hypertension  and
hypercholesterolemia  (odds  ratio  3.143,  95%  conﬁdence  interval  1.004–9.842,  p =  0.049).
Conclusion:  CAVI  is an  independent  parameter  which  reﬂects  coronary  atherosclerosis  in  patients  with
abnormal  glucose  metabolism.  CAVI  can  be  a useful  tool not  only  to  assess  arterial  stiffness,  but  also  to
evaluate  the  risk  for subclinical  coronary  atherosclerosis  in asymptomatic  patients.
© 2012  Japanese  College  of Cardiology.  Published  by  Elsevier  Ltd.  All rights  reserved.ntroduction
Abnormal glucose metabolism is associated with an increased
isk for cardiovascular disease and mortality [1–4]. The increased
rterial stiffness associated with abnormal glucose metabolism
lays a key role in the pathophysiology [5–7]. Increased central
nd peripheral arterial stiffness occur not only in diabetic patients,
ut also in those with impaired glucose metabolism [2,5]. The
ssociation of glucose tolerance and arterial stiffness has been
tudied using various methods, such as the aortic augmenta-
ion index, height-adjusted carotid-femoral transit time, and pulse
ave velocity (PWV) [8].  Although many tools are available to
∗ Corresponding author at: Division of Cardiology, Department of Internal
edicine, Healthcare System Gangnam Center, Seoul National University Hospi-
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914-5087/$ – see front matter © 2012 Japanese College of Cardiology. Published by Else
ttp://dx.doi.org/10.1016/j.jjcc.2012.07.005estimate arterial stiffness [9–12], the accuracy of these measure-
ments remains in doubt since these parameters are affected by the
blood pressure at the time of measurement.
Cardio-ankle vascular index (CAVI) is an index which reﬂects the
stiffness of the whole arterial segments from aorta to tibial artery
and involves the measurement of PWV  and blood pressure. The
major advantage of CAVI is that it is unaffected by blood pressure.
Additionally, it is easy to measure and is superior in reproducibility
compared to PWV. There have been reports that CAVI is associ-
ated with atherosclerotic disease [13–15]. However, the association
between coronary atherosclerosis and arterial stiffness using CAVI
has been studied in only speciﬁc subgroups of patients, such as
those with known coronary artery disease.
In this study, we  aimed to investigate the association of arterial
stiffness as measured by CAVI and coronary atherosclerosis using
coronary artery computed tomography (CT) in an asymptomatic
general population, with special interest in subjects with abnormal
glucose metabolism.
vier Ltd. All rights reserved.
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sig. 1. Flow chart showing patient selection. CAVI, cardio-ankle vascular index;
TCA, computed tomography coronary angiography.
ethods
tudy subjects
Between January 2011 and July 2011, 755 asymptomatic Korean
ubjects underwent CAVI at Seoul National University Hospi-
al Healthcare System Gangnam Center. Excluding patients with
igniﬁcant valvular heart disease, known coronary artery dis-
ase, or peripheral artery disease, only the asymptomatic subjects
ere screened for the study. Only the patients with CT coro-
ary angiography on the same day were included in the study
n = 544). Relevant past medical histories such as hypertension
nd hypercholesterolemia and current medications were obtained
rom medical questionnaires. The subjects were divided into two
roups: (1) normal glucose control and (2) impaired glucose con-
rol. Impaired glucose metabolism was deﬁned as a fasting blood
ugar (FBS) ≥100 mg/dL, glycated hemoglobin (HbA1C) ≥5.7%, or
he use of medications for diabetes mellitus. An additional 13
atients were excluded from the study due to the lack of laboratory
esting (Fig. 1). A total of 531 patients were ultimately included in
he analysis. The study protocol was conﬁrmed and approved by the
nstitutional Review Board of Seoul National University Hospital.
easurement of anthropometric and laboratory parameters
The blood pressure, body weight, height, and waist circum-
erence were measured on the day of the examination. For
easurement of cholesterol levels and glucose screening tests,
ll study subjects were fasted for 12 h or longer before the blood
est. Total cholesterol, triglyceride (TG), high-density lipoprotein
holesterol, low-density lipoprotein (LDL) cholesterol, FBS, and
bA1C were measured.
easurement of CAVI
CAVI was measured with a VaSera VS-1000 (Fukuda Denshi Co.
td, Tokyo, Japan) by the methods described previously [16,17].
rachial pulse pressure was measured using an automatic cuff
scillometric device with the subject seated after a 5-min rest. The
verage of two readings was used to determine systolic and dias-
olic pressures and pulse pressure. Cuffs were applied to both upper
rms and ankles with the subject in the supine position. The mea-
urement was performed after 10 min  of rest. A phonocardiogram
as placed at the right sternum border in the second intercostal
pace and electrocardiogram leads were attached to both wrists.ology 60 (2012) 372–376 373
PWV  was calculated by dividing the vascular length (L) by the time
(T) taken for the pulse wave to propagate from the aortic valve to
the ankle. Since the starting time of the blood stream from the aor-
tic valve is difﬁcult to identify from the valve’s opening sound, T
is difﬁcult to obtain; therefore, T was calculated by summing the
time between the rise of the brachial pulse wave and the rise of
ankle pulse wave, and the time between the closing sound of the
aortic valve and the notch of the brachial pulse wave. CAVI was
determined using the following equation:
CAVI = a
[(
2
P
)
× ln
(
Ps
Pd
)
× PWV2
]
+ b (1)
where Ps and Pd are systolic and diastolic blood pressures, respec-
tively, P  is Ps–Pd,  is blood density, and a and b are constants.
The average value of right and left CAVI was used for analysis.
Computed tomography
After CAVI measurement, coronary CT was performed using a
256-slice multi-detector CT scanner (Brilliance iCT 256; Philips
Medical Systems, Cleveland, OH, USA). A standard scanning proto-
col was  applied, with 128 × 0.625 mm section collimation, 0.27 ms
rotation time, 120 kV tube voltage, and 800 mA  s tube current. All
scans were performed with electrocardiogram-gated dose mod-
ulation. Patients with heart rates ≥60 beats per min  before CT
received 50–100 mg  of metoprolol. A bolus of 70 ml iomeprol
(Iomeron, Bracco Imaging SpA, Milan, Italy) was injected intra-
venously (5.0 ml/s) followed by a 25 ml  saline bolus injection. In
case of motion artifact, additional reconstructions were performed.
Coronary artery calcium score (CACS) was  calculated quantitatively
according to the method described by Agatston et al. [18]. Mean
radiation exposure was  3 mSv.
Statistical analysis
Data are expressed as mean ± standard deviation. Categorical
variables were compared using chi-square analysis. For continu-
ous variables, unpaired Student’s t-test was  used for comparison,
and bivariate correlation analyses with Spearman correlations
were used for evaluation of relationships between variables. Lin-
ear regression analysis was  applied to evaluate correlation of CAVI
with continuous parameters, and step-wise multivariate regres-
sion analysis was  used to evaluate signiﬁcance of CAVI in detecting
coronary atherosclerosis, with adjustment of covariates. A cut-off
level of CAVI was  provided by using receiver operating characteris-
tic (ROC) curve and area under the curve. For all statistical analyses,
statistical software package (SPSS 17.0, SPSS Inc, Chicago, IL, USA)
was used and a p-value of less than 0.05 was considered statistically
signiﬁcant.
Results
Baseline characteristics
Among 531 subjects, 158 subjects were normoglycemic and
373 subjects showed abnormal glucose metabolism. Baseline char-
acteristics for both groups are shown in Table 1. The prevalence
of hypertension and hypercholesterolemia were higher in sub-
jects with abnormal glucose metabolism, whereas smoking status
did not show a difference. The subjects with abnormal glucose
metabolism were older, had higher body mass index, TG, and urine
albumin to creatinine ratio. In patients with abnormal glucose
metabolism, CAVI was higher and CACS score and degree of stenosis
were both greater, compared to the normal group.
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Table  1
Baseline characteristics.
Normal
(n = 158)
Subjects with
abnormal glucose
metabolism
(n = 373)
p-Value
Age, years 56 ± 8 58 ± 9 0.001
Male sex, n(%) 105 (66.5%) 262 (70.2%) 0.223
HTN, n(%) 39 (24.7%) 139 (37.3%) 0.005
ACE  inhibitor/ARB 16 (10.1%) 77 (20.1%) 0.005
CCB 9 (5.7%) 66 (17.7%) 0.001
BB 7  (4.4%) 17 (4.6%) 0.949
Diuretics 6 (3.8%) 27 (7.2%) 0.133
Dyslipidemia, n(%) 22 (13.9%) 124 (33.2%) <0.001
Statin 10 (6.3%) 93 (24.9%) <0.001
Smoking, n(%) 0.840
Never-smoker 118 (83.1%) 283 (82.7%)
Ex-smoker 4 (2.8%) 7 (2.0%)
Current smoker 20 (14.1%) 52 (15.2%)
BMI, kg/m2 24 ± 3 25 ± 3 <0.001
WC,  mm 84 ± 8 88 ± 8 <0.001
SBP, mmHg  118 ± 14 119 ± 13 0.278
DBP, mmHg 78 ± 10 77 ± 9 0.646
FBS,  mg/dL 91 ± 6 111 ± 24 <0.001
HbA1C, % 5.4 ± 0.2 6.1 ± 0.8 <0.001
Uric acid, mg/dL 5.5 ± 1.3 5.9 ± 1.5 0.002
Total cholesterol, mg/dL 198 ± 32 198 ± 37 0.967
Triglyceride, mg/dL 114 ± 60 137 ± 96 0.005
HDL-cholesterol, mg/dL 52 ± 12 51 ± 12 0.159
LDL-cholesterol, mg/dL 127 ± 27 127 ± 33 0.990
hsCRP, mg/dL 0.09 ± 0.11 0.16 ± 0.36 0.034
UACR 0.008 ± 0.016 0.015 ± 0.048 0.034
Creatinine, mg/dL 0.86 ± 0.17 0.89 ± 0.19 0.167
GFR, ml/min/1.73 m2 87 ± 14 85 ± 17 0.249
CAVI, mean 7.5 ± 0.8 7.9 ± 1.0 <0.001
CAVI ≥ 8.0 37 (23.4%) 150 (40.2%) <0.001
CACS 45 ± 144 108 ± 307 0.001
0  110 (69.6%) 179 (48.0%) <0.001
0  < CACS < 100 31 (19.6%) 114 (30.6%)
100 < CACS < 400 11 (7.0%) 58 (15.5%)
CACS ≥ 400 6 (3.8%) 22 (5.9%)
Degree of stenosis, % 8 ± 14 14 ± 17 <0.001
0%  111 (70.3%) 191 (51.2%) 0.001
1–49% 43 (27.2%) 166 (44.5%)
50–69% 4 (2.5%) 11 (2.9%)
≥70% 0 (0%) 5 (1.3%)
ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker; BB, beta
blocker; BMI, body mass index; CAVI, cardio-ankle vascular index; CACS, coronary
artery calcium score; CCB, calcium-channel blocker; DBP, diastolic blood pressure;
FBS,  fasting blood sugar level; GFR, glomerular ﬁltration rate; HbA1C, glycated
hemoglobin; HDL-cholesterol, high-density lipoprotein cholesterol; hsCRP, high-
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Table 2
Univariate correlation analysis in patients with abnormal glucose metabolism: asso-
ciation with arterial stiffness measured by cardio-ankle vascular index.
Parameter r p-Value
Age, years 0.609 <0.001
Waist circumference, mm −0.001 0.98
Fasting blood sugar, mg/dL 0.167 0.001
Glycated hemoglobin, mg/dL 0.277 <0.001
Total cholesterol, mg/dL −0.136 0.008
Triglyceride, mg/dL −0.019 0.714
High-density lipoprotein cholesterol, mg/dL −0.053 0.306
Low-density lipoprotein cholesterol, mg/dL −0.124 0.017
Creatinine, mg/dL 0.064 0.217
Urine albumin to creatinine ratio 0.135 0.011
High-sensitivity C-reactive protein, mg/dL 0.086 0.133
Systolic blood pressure, mmHg 0.306 <0.001
Diastolic blood pressure, mmHg 0.015 0.777
Glomerular ﬁltration rate, ml/min/1.73 m2 −0.12 0.021
Coronary artery calcium score 0.167 0.001
Degree of coronary artery stenosis, % 0.182 <0.001
nary artery disease. As a cut-off value, CAVI ≥8 was  fairly accurate
in predicting ≥50% coronary artery stenosis.
Table 3
Multivariate analysis: correlation with coronary artery stenosis ≥50% in prediabetic
and diabetic population.
Parameters Odds ratio 95% conﬁdence interval p-Value
Agea 1.223 0.244–6.136 0.807
Male sex 2.949 0.625–13.910 0.172
Hypertension 0.413 0.141–1.206 0.106ensitivity C-reactive protein; HTN, hypertension; LDL-cholesterol, low-density
ipoprotein cholesterol; SBP, systolic blood pressure; UACR, urine albumin to crea-
inine ratio; WC,  waist circumference.
ssociation of arterial stiffness with other parameters in patients
ith abnormal glucose metabolism
As shown in Table 2, patients with abnormal glucose
etabolism were evaluated for an association of CAVI with
ther clinical parameters. Age, FBS, HbA1C, total cholesterol, LDL-
holesterol, urine albumin to creatinine ratio, glomerular ﬁltration
ate, CACS, and degree of stenosis detected by CT were signiﬁ-
antly associated with CAVI. The two parameters reﬂecting glucose
etabolism, FBS and HbA1C were both positively associated with
AVI, reﬂecting increasing arterial stiffness.
Using ROC, optimal cut-off value of CAVI for detecting signif-
cant stenosis was evaluated. In patients with abnormal glucose
etabolism, cut-off level of CAVI to predict 50% of coronary artery
tenosis detected by CT was 8.0, with sensitivity of 69% and speci-
city of 61%. The area-under-the-curve was 0.713 in subjects with
bnormal glucose metabolism, whereas it was only 0.550 in nor-
oglycemic subjects. In patients with normal glucose levels, CAVI
8.0 was found in 37 patients whereas in patients with abnormalr, correlation coefﬁcient.
glucose metabolism, CAVI ≥8.0 was  found in 150 patients (23.4%
vs. 40.2% respectively, p < 0.001).
CAVI to predict coronary atherosclerosis in patients with
abnormal glucose metabolism: a multivariate analysis
CAVI, as a continuous parameter, has shown positive association
with CACS and degree of stenosis from CT coronary angiography. As
a categorical variable with a cut-off level of ≥8, odds ratio (OR) for
prediction of 50% stenosis in CT was 3.450 (95% conﬁdence interval
[CI] 1.174–10.143, p = 0.024). Multivariate analysis was  then per-
formed to adjust other risk factors for coronary atherosclerosis. Age,
male sex, hypertension, and hypercholesterolemia were included
in the model. Age was considered a categorical variable with 50 and
60 years of age as cut-off levels for men  and women respectively.
From previous studies of coronary atherosclerosis in asymptomatic
Korean populations [19–21],  it was  uncommon for men  <50 years
of age and women  <60 years of age to have any coronary artery
calciﬁcation, and thus for age, cut-off level of 50 for men  and 60 for
women was applied for multivariate analysis. In the multivariate
model, CAVI ≥8 was still an independent parameter to detect 50%
coronary artery stenosis after adjusting covariates as listed above
(OR 3.143, 95% CI 1.004–9.842, p = 0.049, Table 3).
Discussion
The main ﬁnding of this study is that CAVI reﬂects coronary
atherosclerosis in asymptomatic patients with abnormal glucose
metabolism, even after adjusting for known risk factors of coro-Hypercholesterolemia 2.865 0.623–13.162 0.176
CAVI ≥ 8 3.143 1.004–9.842 0.049
CAVI, cardio-ankle vascular index.
a Cut-off values for age: ≥50 in males, ≥60 in females.
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rterial stiffness in patients with abnormal glucose metabolism
Increased arterial stiffness has been established as a risk fac-
or for coronary artery disease and coronary artery plaque burden
21–23]. Arterial stiffness in patients with diabetes mellitus (DM)
r impaired glucose metabolism has also been studied extensively
sing various tools such as augmentation index, carotid-femoral
ransit time, or arterial compliance [8,24–26]. Central and periph-
ral arterial stiffness both have shown an association with impaired
lucose metabolism. However, the parameters used for measure-
ent of arterial stiffness are limited and affected by blood pressure
uring the measurement.
CAVI has an advantage since it is independent of blood pres-
ure [27] and has been studied recently in various populations.
akenaka et al. [28] reported that CAVI is higher in diabetics and
atients with a history of cardiovascular disease. Yet, its use in
symptomatic patients with impaired glucose metabolism which
ncludes pre-diabetic population has not been studied. For the ﬁrst
ime, we evaluated CAVI in relation to coronary atherosclerosis
rom CT in asymptomatic general population with different glucose
etabolism.
AVI and coronary atherosclerosis in subjects with abnormal
lucose metabolism
Increased arterial stiffness in patients with abnormal glucose
etabolism is associated with cardiovascular outcome. Diabetes
epresents one of the major risk factors for coronary artery dis-
ase and is even considered an ‘angina equivalent.’ An association
etween CAVI and coronary artery calciﬁcation in patients with
iabetes has been demonstrated [15]. In this study, we not only
valuated coronary artery calciﬁcation but also the degree of steno-
is and the calcium score as parameters of coronary atherosclerosis.
n a population with abnormal glucose metabolism, CAVI showed
n independent association with degree of coronary artery stenosis,
ven after adjusting for covariates.
se of CAVI in evaluating the risk for subclinical atherosclerosis
CAVI is a non-invasive, easily-measured, and inexpensive
ethod to measure arterial stiffness. Unlike CT, there is no radia-
ion exposure. As we have shown, CAVI reﬂects subclinical coronary
therosclerosis and can be used as a screening method for evalu-
ting the risk for subclinical coronary atherosclerosis. Although CT
s a useful noninvasive tool to determine the presence of coronary
rtery disease, routine use of CT is not recommended according to
he current guideline, especially in an asymptomatic population.
he radiation dose and cost-effectiveness are questions remaining
o be answered.
onclusion
CAVI reﬂects coronary atherosclerosis in asymptomatic patients
ith abnormal glucose metabolism, even after adjusting for known
isk factors of coronary artery disease. As a cut-off value, CAVI ≥8
as fairly accurate in predicting ≥50% coronary artery stenosis.
onsidering the advantages of CAVI, it can be used as one of the
creening tools to reﬂect coronary atherosclerosis in asymptomatic
atients, especially in those with abnormal glucose metabolism.onﬂict of interest
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